<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Cayman Journal - Trevi Therapeutics Inc (TRVI)</title>
    <description>Latest news, press releases, and SEC filings for Trevi Therapeutics Inc (TRVI)</description>
    <link>https://caymanjournal.com/stock/TRVI</link>
    <language>en-us</language>
    
    <copyright>Copyright 2026, Cayman Journal</copyright>
    <managingEditor>editorial@caymanjournal.com (Editorial Team)</managingEditor>
    <webMaster>webmaster@caymanjournal.com (Web Master)</webMaster>
    <lastBuildDate>Tue, 28 Apr 2026 01:19:31 GMT</lastBuildDate>
    <ttl>60</ttl>
    <atom:link href="https://caymanjournal.com/stock/TRVI/feed.xml" rel="self" type="application/rss+xml" />
    <image>
      <url>https://caymanjournal.com/logo.png</url>
      <title>Cayman Journal</title>
      <link>https://caymanjournal.com</link>
      <width>144</width>
      <height>144</height>
    </image>

    <item>
      <title>ARS — Trevi Therapeutics, Inc.</title>
      <description>I am unable to summarize the filing because the actual document content was not provided. The structured tags indicated a filing (`&lt;PDF&gt;&lt;/PDF&gt;`) but contained no text or data.

Please provide the full text, or the PDF of, the SEC filing for Trevi Therapeutics, Inc. (TRVI). Once I receive the documen</description>
      <link>https://caymanjournal.com/stock/TRVI/sec-filing/0001193125-26-166694</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/TRVI/sec-filing/0001193125-26-166694</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>DEF 14A — Trevi Therapeutics, Inc.</title>
      <description># 📑 What This Document Is 📰
This document is a Definitive Proxy Statement, which is essentially an official packet of instructions for the company&apos;s annual meeting. 👉 It tells stockholders exactly what topics will be voted on, who the leaders are, and how they must vote their shares. The filing d</description>
      <link>https://caymanjournal.com/stock/TRVI/sec-filing/0001193125-26-166695</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/TRVI/sec-filing/0001193125-26-166695</guid>
      <pubDate>Tue, 21 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item><item>
      <title>PRE 14A — Trevi Therapeutics, Inc.</title>
      <description># 🧾 What This Document Is
This is a **PRE 14A**, or **Preliminary Proxy Statement**. Think of it as a &quot;preview&quot; and an invitation. Trevi Therapeutics is sending it to its shareholders ahead of the **2026 Annual Meeting**. Its job is to explain what will be voted on, provide background info, and rec</description>
      <link>https://caymanjournal.com/stock/TRVI/sec-filing/0001193125-26-151354</link>
      <guid isPermaLink="true">https://caymanjournal.com/stock/TRVI/sec-filing/0001193125-26-151354</guid>
      <pubDate>Fri, 10 Apr 2026 00:00:00 GMT</pubDate>
      
      <category>SEC Filing</category>
      
    </item>
  </channel>
</rss>